1. Department of Community Health Sciences, Cumming School of Medicine and O’Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada
2. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
3. Department of Economics, University of Calgary, Calgary, Alberta, Canada